| Formation of a protein corona on the surface of extracellular vesicles in blood plasma EÁ Tóth, L Turiák, T Visnovitz, C Cserép, A Mázló, BW Sódar, AI Försönits, ... Journal of extracellular vesicles 10 (11), e12140, 2021 | 243 | 2021 |
| GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas Z Hujber, G Horváth, G Petővári, I Krencz, T Dankó, K Mészáros, H Rajnai, ... Journal of Experimental & Clinical Cancer Research 37, 1-12, 2018 | 38 | 2018 |
| Inhibition of metabolic shift can decrease therapy resistance in human high-grade glioma cells G Petővári, T Dankó, I Krencz, Z Hujber, H Rajnai, E Vetlényi, R Raffay, ... Pathology & Oncology Research 26, 23-33, 2020 | 24 | 2020 |
| The role of metabolic ecosystem in cancer progression—metabolic plasticity and mTOR hyperactivity in tumor tissues A Sebestyén, T Dankó, D Sztankovics, D Moldvai, R Raffay, C Cervi, ... Cancer and Metastasis Reviews 40 (4), 989-1033, 2021 | 23 | 2021 |
| Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells G Petővári, Z Hujber, I Krencz, T Dankó, N Nagy, F Tóth, R Raffay, ... Cancer Cell International 18, 1-17, 2018 | 23 | 2018 |
| IFITM1 expression determines extracellular vesicle uptake in colorectal cancer A Kelemen, I Carmi, Á Oszvald, P Lőrincz, G Petővári, T Tölgyes, K Dede, ... Cellular and Molecular Life Sciences 78, 7009-7024, 2021 | 22 | 2021 |
| Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells Z Hujber, G Petővári, N Szoboszlai, T Dankó, N Nagy, C Kriston, I Krencz, ... Journal of Experimental & Clinical Cancer Research 36, 1-12, 2017 | 21 | 2017 |
| Rapamycin plus doxycycline combination affects growth arrest and selective autophagy-dependent cell death in breast cancer cells T Dankó, G Petővári, D Sztankovics, D Moldvai, R Raffay, P Lőrincz, ... International Journal of Molecular Sciences 22 (15), 8019, 2021 | 20 | 2021 |
| In situ metabolic characterisation of breast cancer and its potential impact on therapy G Petővári, T Dankó, AM Tőkés, E Vetlényi, I Krencz, R Raffay, M Hajdu, ... Cancers 12 (9), 2492, 2020 | 16 | 2020 |
| 3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue … D Sztankovics, D Moldvai, G Petővári, R Gelencsér, I Krencz, R Raffay, ... Pathology and Oncology Research 29, 2023 | 15 | 2023 |
| Characterisation of 3D bioprinted human breast cancer model for in vitro drug and metabolic targeting T Dankó, G Petővári, R Raffay, D Sztankovics, D Moldvai, E Vetlényi, ... International Journal of Molecular Sciences 23 (13), 7444, 2022 | 13 | 2022 |
| The SDHB Arg230His mutation causing familial paraganglioma alters glycolysis in a new Caenorhabditis elegans model É Saskői, Z Hujber, G Nyírő, I Likó, B Mátyási, G Petővári, K Mészáros, ... Disease models & mechanisms 13 (10), dmm044925, 2020 | 13 | 2020 |
| Characterization of mTOR activity and metabolic profile in pediatric rhabdomyosarcoma L Felkai, I Krencz, DJ Kiss, N Nagy, G Petővári, T Dankó, T Micsík, ... Cancers 12 (7), 1947, 2020 | 12 | 2020 |
| SPOCK1 promotes the development of hepatocellular carcinoma L Váncza, K Karászi, B Péterfia, L Turiák, K Dezső, A Sebestyén, ... Frontiers in oncology 12, 819883, 2022 | 10 | 2022 |
| The effects of different mTOR inhibitors in EGFR inhibitor resistant colon carcinoma cells T Sticz, A Molnár, T Dankó, Z Hujber, G Petővári, N Nagy, G Végső, ... Pathology & Oncology Research 25, 1379-1386, 2019 | 8 | 2019 |
| Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response F Sipos, B Bohusné Barta, Á Simon, L Nagy, T Dankó, RE Raffay, ... Pathology and Oncology Research 28, 1610322, 2022 | 7 | 2022 |
| Overexpression of human syndecan-1 protects against the diethylnitrosamine-induced hepatocarcinogenesis in mice A Reszegi, K Karászi, G Tóth, K Rada, L Váncza, L Turiák, Z Schaff, A Kiss, ... Cancers 13 (7), 1548, 2021 | 7 | 2021 |
| Metabolic adaptation as potential target in papillary renal cell carcinomas based on their in situ metabolic characteristics I Krencz, E Vetlényi, T Dankó, G Petővári, D Moldvai, D Sztankovics, ... International Journal of Molecular Sciences 23 (18), 10587, 2022 | 6 | 2022 |
| Formation of a protein corona on the surface of extracellular vesicles in blood plasma., 2021, 10, p. e12140 E Tóth, L Turiák, T Visnovitz, C Cserép, A Mázló, BW Sódar, AI Försönits, ... DOI: https://doi. org/10.1002/jev2 12140, 0 | 5 | |
| SPOCK1 overexpression suggests poor prognosis of ovarian cancer L Váncza, A Horváth, L Seungyeon, A Rókusz, K Dezső, A Reszegi, ... Cancers 15 (7), 2037, 2023 | 4 | 2023 |
